InvestorsHub Logo
Followers 105
Posts 16348
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Thursday, 11/30/2023 8:02:06 AM

Thursday, November 30, 2023 8:02:06 AM

Post# of 1106
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News